Biotechnology
- 722.701
- +28.881+4.16%
Fresh funds from the Middle East are here to support! Saudi Arabia's first investment in china etf is about to be listed.
Saudi Arabia's first investment in china etf is expected to be listed on October 30, with an estimated fundraising size exceeding 10 billion Hong Kong dollars.
Zai Lab Stock Rockets 24% on Data for Lung Cancer ADC Drug
Indaptus Therapeutics Signs Clinical Supply Agreement With Beigene
Existing for over 14 years, Yunfeng RMB Fund Phase I may successfully come to an end.
①Shanghai Yunfeng has had a commercial change, with the registered capital reduced from 0.29 billion RMB to 10 million RMB; ②Yunfeng Fund stated that it has currently established five batches of RMB investment funds and four batches of USD investment funds. The settlement of early funds indicates that the company is further optimizing its strategy and portfolio, strengthening the investment layout of subsequent funds.
Bullish on A-shares? Foreign capital bypasses Hong Kong stock ETFs, with institutions suggesting that incremental capital for Chinese stocks may reach 40 billion US dollars.
Institutions predict that Chinese stock potential incremental funds may reach 40 billion US dollars. Which directions will be the focus of increasing positions?
What happened during the National Day holiday at home and abroad? Here is a summary of important financial news.
①The Shanghai Stock Exchange: Will extend the acceptance of designated trading order instructions starting from October 8; Goldman Sachs has raised the Chinese stock market to "overweight", expecting a further increase of 15-20%; ②The Hong Kong stock market is booming, with a high growth in the number of brokerage account openings and margin trading data in Hong Kong in the past week; Many places have introduced optimization policies for real estate, and the market has responded positively.
Weekend reading | merck's 'harem battle'
为了让K药价值持续放大，默沙东开启了一场全球ADC寻觅之旅。
The cumulative amount exceeds 140 billion! Nearly 2,000 A-share listed companies have implemented buybacks since the beginning of this year, and the individual stock buyback amount ranking has been released.
①In the year, 1968 A-share listed companies have implemented repurchases, with a cumulative repurchase amount exceeding 140 billion yuan; ②wuxi apptec's repurchase amount reached 3 billion yuan, ranking first, hangzhou hikvision digital technology's repurchase amount of 2.894 billion yuan ranked second, see the ranking of repurchase amounts of A-share listed companies for the year (see table).
Hong Kong stocks become the "hottest" stock market in the world! The Hang Seng Index has risen nearly 40% so far this year, with brokerage stocks surging sixfold in five days. How will the future market evolve?
It is noteworthy that brokerage stocks, as the vanguards of the bull market, play the role of "front-runners" in this current uptrend. Moreover, Chinese-affiliated brokerage stocks in the Hong Kong market have shown astonishing increases, indicated by the gains over the past five trading days.
Hong Kong stocks violently rallied! The Hang Seng Index surged more than 4%, brokerages and real estate took off again, these four major unexpected events are worth paying attention to.
The situation in the Hong Kong stock market is ever-changing!
Express News | Contract research organizations surged violently in the final trading session of Hong Kong stocks, with Tigermed soaring nearly 28%, Pharmaron rising over 22%, Joinn Laboratories up more than 17%, Wuxi Apptec up over 16%, and Wuxi Bio up over 14%.
Who's buying? The A-share market is closed, but the Hong Kong stock market is still going strong! There's a big shift in foreign capital underway.
According to the latest report published by Goldman Sachs, after the People's Bank of China announced easing measures and the September Political Bureau meeting, mainland consumer stocks rebounded strongly by an average of about 32% in the past week.
Hong Kong stocks surged for the fourth day and broke through the top again, with southbound funds buying 500 billion yuan explosively within the year. Northbound funds went on a shopping spree in September, selling Alibaba and Meituan, as well as Tencent.
In September, the amount of southbound funds inflow was 30 billion Hong Kong dollars, showing a slight decrease compared to the previous month, but still maintaining a trend of net fund inflow for 15 consecutive months.
Hong Kong stocks have been soaring for days on heavy volume, haven't jumped on board yet? These directions are still worth paying attention to.
In recent days, the heavy-duty policy bullish continues to catalyze, with large funds actively buying assets in China, and the market's bullish sentiment towards China has been fully ignited. Beneficiary sectors have already risen in advance. Lowering mortgage rates is bullish for consumer spending, with sectors like alcohol, gold, and jewelry taking the lead, while opportunities for biomedical and real estate stocks are worth looking forward to.
Futu Morning Post | S&P hits new high for the 41st time this year! Goldman Sachs: October volatility may rebound; Significant cooling in the labor market, Federal Reserve officials support further rate cuts.
usa mortgage rates fell again, triggering a large-scale refinancing wave; The US House of Representatives passed a short-term funding bill to keep the government from shutting down before December 20; OECD has raised its global economic growth expectations, forecasting a 3.2% GDP growth rate for the global economy in 2024.
Another wave! The revised version of the 'Biosecurity Bill' in the U.S. Senate has been included in the legislative schedule, but the suspense of 'crossing the pass' still remains.
①On the 23rd local time in the United States, the U.S. Senate included Amendment S.3558 in the Senate legislative agenda by general order, and determined the new name of the bill, with unusual movements in the pharmaceutical industry. ② Amendment S.3558 did not incorporate the "grandfather clause" regarding exemptions period from the U.S. House version of the Biosecurity Act, nor made any changes to the entities involved.
Daily Bull and Bear | The Hang Seng Index surged to 18,400 and then fell back, with the highest addition of heavy positions in the bull market; picc p&c rose by 4.26%, with subscription warrants doubling.
Hang Seng Index closed flat on Monday, down 11.46 points at 18,247.11, hitting a high of 18,426.92 intraday. In terms of capital trend, Hang Seng Index saw a net inflow of 49 million Hong Kong dollars from weak positions and a net inflow of 0.784 million Hong Kong dollars from strong positions. The top five stocks with inflow of capital from strong positions are Meituan, BYD Company Limited, Kuaishou, Hong Kong Exchanges and Clearing, and WuXi Biologics.
The increase in Middle East capital is also coming! The first Chinese Hong Kong ETF in Saudi Arabia has been approved.
Saudi Capital Market Authority announced that AlBilad Investment Company, a subsidiary of Bank Albilad, plans to establish an ETF investing in stocks in Hong Kong, China. The application has been approved.
Massive layoffs? Remegen responds: it is a normal business optimization. The new indications for Tai Itasi will be submitted for listing in the near future.
①Regarding the rumor of layoffs circulating on the internet, the secretary of the board of directors of remegen stated that the company started to streamline its business from last year, and the optimization of positions and personnel is based on work needs without a rigid ratio; ②The other party revealed that the severe myasthenia gravis indication of the targeted drug tazepamab will be applied for market approval in the near future. However, in the market, tazepamab is facing multiple competitions.
BeiGene Initiated at Outperform at JMP Securities on Strength of Brukinsa